BD Technologies develops next generation technologies aligned with BD’s business strategies. BD Technologies, through the BioVenture Center incubation program, also accelerates the development of early stage life sciences companies working collaboratively with BD.
BD Technologies develops proprietary technology platforms in the following areas:
|
Parenteral & BioMaterial Technologies
Mission
Maximize therapeutic effectiveness of biopharmaceutical products via non- and minimally-invasive drug delivery technologies and maintain or improve the performance of biomolecules via biomaterial technologies
Overview
The Parenteral & BioMaterial Technologies group at BD Technologies is developing novel and proprietary drug delivery and biomaterial technologies designed to enhance the therapeutic value and improve the performance of biomolecules. Over the past 100 years, BD has developed a wealth of knowledge about effective parenteral drug delivery. An example of one platform technology being developed is microneedle delivery for intradermal administration, where BD has extensive expertise with a variety of pharmaceutical agents.
Advanced Diagnostics
Mission
To develop next-generation in vitro diagnostics that address healthcare needs in the developed and the developing world
Overview
The Advanced Diagnostics group is developing novel biosensor detection systems and next-generation in vitro diagnostic instrument systems to enable rapid, high sensitivity detection of diseases in a variety of health care settings. In particular, we are developing technologies that enable better and faster detection of infectious diseases, such as tuberculosis and malaria, which most severely afflict those living in developing countries.
Cell and Tissue Engineering
Mission
To develop technology for products and services that will provide ample and safe supplies of human cells for research, drug discovery and therapy
Overview
The Cell and Tissue Technology group builds on BD's core capabilities and market leadership in flow cytometry and cell analysis. BD Technologies’ core technology is a unique high throughput systems biology platform that combines automation technologies with state-of-the-art bioinformatics. This technology platform enables efficient identification of methods and cell culture environments for producing cells for therapy, drug discovery and research.
Discovery Platform
To meet customers' requirement for defined culture environments (media, surfaces, and culture vessels) - as well as for more physiologically relevant cells - BD scientists have developed an advanced combinatorial screening program, the Discovery Platform. Learn more about Discovery Platform.
Advanced Diabetes Care Technologies
Mission
Advanced Diabetes Care Technology develops technologies for the diagnosis and treatment of Type 1 and 2 Diabetes. Our goal is to develop platform technologies which improve the lives of people with diabetes in the developed and developing world
Overview
The Advanced Diabetes Care focus area is currently developing microneedle-based insulin delivery which improves the drug action profile of insulin, unique glucose monitoring sensors and new technologies appropriate for the developing world.
|
|
|
|
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন